newbusiness@systoleremedies.com
Dist Sirmaur Himachal-173030
15 September 2026 | By Admin
The Pharma Liquid Manufacturing Unit is among the most stringent areas of the pharmaceutical industry that require tighter process control, faster changeover between batches, and higher levels of hygiene discipline compared to the majority of solid dosage units. Liquid dosage forms – syrups, suspensions, oral solutions and drops – are more sensitive chemically and microbiologically compared to tablets and capsules, meaning that even minor deviations in mixing, filtration, or temperature control may ruin the whole batch. Over the last ten years, India has developed itself into one of the most reliable sources of liquid dosage forms on the global market due to its increasing number of WHO-GMP certified manufacturing plants providing products both for the domestic pharma industry and exports.
An Oral Liquid Manufacturing Plant is a specific type of factory that produces medicines that are intended to be ingested through the mouth in the form of liquids - such as cough syrups, antacid suspensions, paediatric drops, tonics and nutrition solutions. While a typical pharmaceutical manufacturing plant will have a wide range of production facilities that manufacture different types of products, an oral liquid manufacturing plant will have mixing rooms with a controlled temperature environment, closed loop water system and special filling lines to prevent contamination between batches. The scope of Oral Liquid Manufacturing usually includes four broad categories: Syrups (based on sugar or sorbitol), Suspensions (insoluble active ingredients distributed in liquid carrier), Solutions (soluble active ingredients) and Emulsions. All these different types of medications require different treatment - for example, suspensions should be constantly agitated to precipitate and syrup requires strict control of sugar inversion to prevent crystallization.
Overall, the above equipment chain forms what distinguishes a professional liquid manufacturing facility from a temporary one because all the valves, gaskets, and vessels have to be compatible with the pharmaceutical formulas.
The processing of each batch manufactured within a Liquid Pharmaceutical Manufacturing plant follows an established set of steps irrespective of the end product being a syrup, suspension, or solution.
Quality control and batch release: Microbial limits test, stability tests, and assay confirmatory test are conducted on the finished samples before the batch is released for shipping.
This sequence is documented at every step through batch manufacturing records, which regulators use to trace a single bottle back to its raw material lot.
Liquid Manufacturing Companies in India cannot function legally unless they comply with the provisions stipulated in Schedule M of the Drugs and Cosmetics Rules, which were amended to be in agreement with WHO-GMP guidelines. These provisions relate to:
Facilities that additionally hold WHO-GMP, ISO 9001, or GLP certifications are generally preferred by brands looking to export, since these certifications are recognised across most regulated and semi-regulated markets.
It is not necessary for all pharma brands to have their own facility to manufacture their products, and this is where Third Party Pharma Manufacturing Companies come into existence. In Liquid Contract Manufacturing, it is the marketing company that provides the formula, branding details, and packaging details, while the manufacturing company does the rest. This kind of partnership is useful for both existing companies that wish to increase their product portfolio and newcomers looking to introduce their product lines.
The following are some of the benefits of partnering with Third Party Medicine Manufacturers: lower cost of initial investment, having access to the machinery and technology that takes several years to develop in-house, and shorter time to market as manufacturing begins once the formula has been completed. It is also important for a good Third Party Pharma Manufacturer to be able to provide documentation and compliance for regulatory drug licenses.
For syrups specifically, a Syrup Third Party Manufacturer brings formulation experience across flavour masking, sugar-free variants, and paediatric-safe excipients — details that are easy to get wrong without prior production history. Brands entering categories like cough and cold, digestive health, or nutraceutical syrups often find that partnering with an experienced Syrup Manufacturing Company shortens their development timeline by months compared to setting up independent manufacturing.
Choosing a third party manufacturing company for liquid products should be considered just as much as a business partnership choice. Some issues that need to be considered before engaging into the contract:
It means that if a pharma third party manufacturing company demonstrates good results in relation to all of these criteria, then there is a high probability of receiving good quality of production with repeated orders, because in this case the importance of quality in liquids is even higher than in any other dosage form.
Q1. How does syrup differ from suspension in liquid manufacturing?
In the case of syrup, there will be a complete dissolution of the active component in the sugar-based medium; in the suspension, however, the active component will be an insoluble particle in the liquid and requires stirring before use.
Q2. Is third party manufacturing a legal process in liquid contract manufacturing in India?
Yes. The concept of third party manufacturing is fully legal in India according to the Indian drug manufacturing laws, on the condition that the manufacturer has a valid licence and that the product formulation of the brand in question is as per Schedule M and the Drugs and Cosmetics Rules.
Q3. How long would it take for the launching of a product through liquid contract manufacturing?
Typically, brands can get the process completed in 4-8 weeks depending upon the documentation and the packaging process.
Pharma Liquid Manufacturing sits at the intersection of precision engineering and regulatory discipline — a single lapse in mixing, filtration, or documentation can affect an entire batch of finished medicine. Whether a brand chooses to build its own Liquid Oral Manufacturing Plant or partner with an established Third Party Pharma Company, the fundamentals remain the same: validated equipment, a documented process flow, and strict adherence to quality standards at every stage. As demand for syrups, suspensions, and oral solutions continues to grow across both domestic and export markets, brands that choose their manufacturing partner carefully — checking certifications, capacity, and formulation expertise, position themselves to scale with fewer quality risks and a more predictable supply chain.
Must Read: Pharma Contract Manufacturing in India: Emerging Trends and Opportunities in 2026